Post Views: 267 Corrective and Preventive Action (CAPA) in pharma is the structured system used to eliminate the cause of an existing problem (corrective action) and to prevent potential problems from occurring (preventive action). CAPA is a core element of…
Post Views: 306 In pharma, an incident is any unplanned event that disrupts normal operations or creates a potential or actual risk to product quality, patient safety, regulatory compliance, data integrity, environment, or worker safety. Incidents can occur in manufacturing,…
Post Views: 422 In pharma, a deviation is any departure from an approved instruction, established procedure, validated process, specification, or expected condition during manufacturing, packaging, testing, storage, or distribution. Deviations matter because they can affect product quality, patient safety, data…
Post Views: 1,139 Regulatory affairs (RA) in pharma is a critical function that ensures pharmaceutical products meet legal and safety standards before they reach the market. It involves compliance with national and international regulations governing drug development, approval, manufacturing, marketing,…
Post Views: 1,083 Supply Chain Management (SCM) in pharma is the end-to-end control of materials, information, quality, and product flow from API/excipient suppliers to the patient—while maintaining GMP/GDP compliance, preventing counterfeits, and assuring continuous availability. The next layer is materials…
Post Views: 1,382 Why Pharma Policies Are Important Key Pharma Policies (Typical Set) You can adapt or expand this list based on your company size and complexity. Structure of a Good Pharma Policy A clear policy document usually includes:
Post Views: 306 Change Control in pharma is the formal, documented system used to propose, evaluate, approve, implement, and review any change that could impact product quality, patient safety, compliance, or data integrity. It is a core element of the…
Post Views: 220 Calibration in pharma is the documented process of verifying and adjusting instruments so they measure accurately and consistently within defined limits. It is a fundamental GMP requirement because critical decisions—batch release, process control, environmental monitoring, and safety—depend…
Post Views: 223 Batch release in pharma is the formal, documented decision that confirms a manufactured batch is fit for sale and patient use. It verifies that teams produced, tested, packed, stored, and reviewed the batch in compliance with approved…
Post Views: 161 A pharma warehouse is a GMP/GDP-controlled storage and distribution area that protects raw materials, packaging materials, intermediates, and finished products so they remain identity-preserved, traceable, and within specification until use or dispatch. Warehousing is critical because poor…
Post Views: 1,756 Self-inspection in the pharmaceutical industry is a critical aspect of Good Manufacturing Practices (GMP) compliance. It involves an internal audit conducted by a pharmaceutical company to evaluate its processes, facilities, and systems to ensure they meet regulatory…
Post Views: 1,495 An Environment Monitoring System (EMS) in pharmaceuticals ensures that critical areas comply with the regulatory requirements for cleanliness, temperature, humidity, pressure, and microbial contamination. It is essential for maintaining product quality, ensuring patient safety, and meeting Good…
You can access this page after paying the subscription fees of 21 ₹ /month only.